Operates Indraprastha Apollo Hospitals in Delhi (Sarita Vihar) and Noida, part of the Apollo Hospitals Group.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 |
| Reserves | 176 | 181 | 234 | 288 | 386 | 505 | 567 | 649 |
| Borrowings | 4 | 3 | 5 | 2 | 34 | 33 | 31 | 37 |
| Other Liabilities | 177 | 157 | 131 | 173 | 212 | 222 | 264 | 214 |
| Total Liabilities | 449 | 432 | 462 | 555 | 723 | 852 | 954 | 991 |
| AssetsFixed Assets | 303 | 283 | 277 | 275 | 347 | 328 | 351 | 365 |
| CWIP | 0 | 3 | 0 | 3 | 0 | 33 | 2 | 3 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 39 | 0 |
| Other Assets | 146 | 145 | 185 | 278 | 376 | 491 | 563 | 624 |
| Total Assets | 449 | 432 | 462 | 555 | 723 | 852 | 954 | 991 |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 75 | 86 | 27 | 94 | 144 | 200 | 157 | 167 |
| Cash from Investing | -17 | -40 | -19 | -74 | -108 | -158 | -111 | -178 |
| Cash from Financing | -44 | -43 | -3 | -3 | -26 | -32 | -46 | -46 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | 58 | 46 | 6 | 65 | 100 | 131 | 120 | 108 |
| FCF Margin | — | — | — | — | — | — | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (18.6×) and current (18.5×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At 28.6% growth and a 19× exit, ₹371 only delivers your return if you pay ₹626. The price is currently baking in 17% growth.
EPS grows 28.6%/yr for 5 years, then fades to 6% over 2, exits at 19×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | 28.6% | 25.76 |
| FY28 | 28.6% | 33.13 |
| FY29 | 28.6% | 42.60 |
| FY30 | 28.6% | 54.78 |
| FY31 | 28.6% | 70.45 |
| FY32 | 17.3% ·fade | 82.64 |
| FY33 | 6.0% ·fade | 87.60 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.